Viral Hepatitis Induces Hepatocellular Cancer: What Can We Learn from Epidemiology Comparing Iran and Worldwide Findings?

被引:14
|
作者
Smolle, Elisabeth [1 ]
Zoehrer, Evelyn [1 ]
Bettermann, Kira [1 ]
Haybaeck, Johannes [1 ]
机构
[1] Med Univ Graz, Inst Pathol, Graz, Austria
关键词
Viral Hepatitis; Carcinoma; Hepatocellular; Iran; C VIRUS-INFECTION; NF-KAPPA-B; TRANSGENIC MICE; CLINICAL-SIGNIFICANCE; LIVER-DISEASE; GENOTYPE-D; CARCINOMA; APOPTOSIS; HEPATOCARCINOGENESIS; PROLIFERATION;
D O I
10.5812/hepatmon.7879
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Context: Several risk factors play the role in the development of hepatocellular carcinoma (HCC) from which chronic hepatitis B and C infections are the most important ones. DNA integration of hepatitis viruses alters the function of critical genes promoting malignant transformation of virus-infected liver cells. Evidence Acquisition: There are remarkable geographic differences in prevalence of chronic viral hepatitis and incidence of HCC. Middle Eastern countries are characterized by a moderate to high prevalence rate of chronic viral hepatitis in the population. This review discusses about epidemiologic findings of hepatitis B and C infections, and HCC, as well as focuses on Middle East countries, particularly Iran. We provide an overview about risk factors, prevention and treatment, and bring up the role of HCC induced by chronic viral hepatitis. Results: Vaccination against hepatitis B virus (HBV) in the early childhood is highly effective to lower infection rates, substantially. For hepatitis C, adequate hygiene when dealing with human blood and screening programs for blood donors can mainly reduce infection rates. As HCC is strongly associated with chronic viral hepatitis, prevention against the infection is crucial for preventing against HCC too. Conclusions: Although prevention and treatment of chronic hepatitis B and C have improved within the last decades even in high-risk countries, effective and sustainable reduction of these infections still needs more actions. Published by Kowsar Corp, 2012. cc 3.0.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Worldwide childhood type 1 diabetes incidence - what can we learn from epidemiology?
    Soltesz, G.
    Patterson, C. C.
    Dahlquist, G.
    [J]. PEDIATRIC DIABETES, 2007, 8 : 6 - 14
  • [2] What can we learn from comparing RTES with CB?
    Jiang, WD
    Ge, TF
    Wu, JL
    Yuan, P
    [J]. PROCEEDINGS OF 2003 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING, VOLS I AND II, 2003, : 1874 - 1877
  • [3] What Can We Learn From Cancer Disparities?
    George, Daniel J.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (03) : 134 - 134
  • [4] What can we learn from cancer registries?
    Burkhardt, Birgit
    [J]. HAEMATOLOGICA, 2023, 109 (03) : 716 - 717
  • [5] What we can learn from cancer care
    Lantis, John
    [J]. JOURNAL OF WOUND CARE, 2017, 26 (01) : S3 - S3
  • [6] Epidemiology of ageing with HIV: what can we learn from cohorts?
    Sabin, Caroline A.
    Reiss, Peter
    [J]. AIDS, 2017, 31 : S121 - S128
  • [7] ATYPICAL FEMORAL FRACTURES: WHAT CAN WE LEARN FROM EPIDEMIOLOGY?
    Cheung, Angela
    [J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 : 603 - 603
  • [8] What Can We Learn From Negative Findings From a Large Cohort?
    Hesse, Morten
    Jones, Sheila
    Pedersen, Mads Uffe
    [J]. JOURNAL OF ADOLESCENT HEALTH, 2024, 75 (01) : 15 - 15
  • [9] Worldwide Fiscal Progressivity: What can we Learn from Subjective Wellbeing Economics?
    Guillermo, Angela Ruiz
    Garcia, Francisco Gomez
    Martos, Luis Palma
    [J]. SCIENTIFIC ANNALS OF ECONOMICS AND BUSINESS, 2023, 70 : 121 - 135
  • [10] WHAT CAN WE LEARN FROM BONE-MARROW DONORS WORLDWIDE (BMDW)
    OUDSHOORN, M
    VANLEEUWEN, A
    DELANGE, P
    SCHIPPER, R
    VANDERZANDEN, HGM
    VANROOD, JJ
    [J]. LEUKEMIA, 1992, 6 : 161 - 162